Fecal microbiota transplantation - analysis of scientific reports, the role of a nurse
DOI:
https://doi.org/10.12775/JEHS.2022.12.01.013Keywords
fecal microbiotaAbstract
Introduction and objective: Presentation of the subject of fecal microbiota transplantation including the role of a nurse.
Review methods: Presentation of the subject of fecal microbiota transplantation including the role of a nurse. Material and methods: A non-systematic review of the literature on the subject of intestinal microflora transplantation was carried out in the available databases: PubMed, Scopus, Web of Science, Google Scholar, EBSCO, ARIANTA. The following keywords were taken into account: microbiota, fecal microbiota transplantation, Clostridium difficile, pseudomembranous enteritis, inflammatory bowel disease. 21 original and review works were qualified: 6 in Polish and 15 in English.
An abbreviated description of the state of knowledge: Fecal microbiota transplantation (FMT) involves introducing into the body of a sick recipient a fecal suspension from a healthy donor. The rate of therapeutic success depends on the main disease entity, appropriate selection of the donor of the fecal suspension. The donor should be tested for the presence of numerous pathogens, determining their type and their quality. FMT is recommended when pharmacotherapy ceases to be effective, it is also an adjunctive treatment in the treatment of many dysbiotic diseases. Summary Fecal microbiota transplantation is indicated in severe pseudomembranous enteritis in patients with Clostridium difficile infection. In the experimental phase, there are new indications for the use of FTM, for example, Parkinson's disease, Alzheimer's disease, but it is contraindicated in irritable bowel syndrome. The role of the nurse is limited to preparing the patient, assisting during the procedure, postoperative care, and educating the patient.
References
Juszczuk K., Grudlewska K., Mikucka A., Gospodarek-Komkowska E.: Postępy Higieny i Medycyny Doświadczalnej: Przeszczepienie mikrobioty jelitowej – metoda leczenia nawracających zakażeń o etiologii Clostridium difficile i innych chorób, 2017, 71, 220-226.
Koppel N., Balskus EP.: Cell Chemical Biology: Exploring and Understanding the Biochemical Diversity of the Human Microbiota, 2016, 23, 18-30.
Grabowska D., Łęga M., Kaźmierczyk-Siedlecka K.: Bromatologia Farmaceutyczna: Znaczenie mikrobiomu jelitowego, suplementacji i leczenia dietetycznego w profilaktyce i leczeniu zespołu policystycznych jajników, 2020, 76(7), 381-387.
Węgielska I., Suliburska J.: Via Medica: Wpływ leków na mikroflorę jelitową, 2016, 1-7.
Wiśniewska K.: Postępy w diagnostyce medycznej: Przeszczep mikrobioty kałowej (FMT) - nadzieja w terapii chorób jelit i autoimmunologicznych, 2020, 100-107.
Martirosian G., Hryniewicz W., Ozorowski T., Pawlik K., Deptuła A.: Zakażenia Clostridioides (Clostridium) difficile: epidemiologia, diagnostyka, terapia, profilaktyka, 2018, 2-25.
Wortelboer K., Nieuwdorp M., Herrema H.: EBioMedicine: Fecal microbiota transplantation beyond Clostridioides difficile infections, 2019 44, 716-729.
Biuletyn: Kwartalnik Okręgowej Izby Pielęgniarek i Położnych: Przeszczep flory jelitowej, 2018, 2, 8-9.
Caldeira LF., Borba HH., Tonin FS., Wiens A., Fernandez-Llimos F., Pontarolo R.: PLoS One: Fecal microbiota transplantation in inflammatory bowel disease patients: A systematic review and meta-analysis, 2020, 18;15(9).
Shen ZH., Zhu CX., Quan YS., Yang ZY., Wu S., Luo WW., Tan B., Wang XY.: World J Gastroenterol: Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and faecal microbiota transplantation, 2018, 7:24(1), 5-14.
Tian Y., Zhou Y., Huang S., Li J., Zhao K., Li X., Wen X., Li XA.:BMC Gastroenterol: Fecal microbiota transplantation for ulcerative colitis: a prospective clinical study, 2019, 4:19(1), 116.
Myneedu K., Deoker A., Schmulson MJ., Bashashati M.: United European Gastroenterol J: Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis, 2019, 7(8), 1033-1041.
Zhang Z, Mocanu V, Cai C., Dang J, Slater L., Deehan EC., Walter J., Madsen KL.: Nutrients: Impact of Fecal Microbiota Transplantation on Obesity and Metabolic Syndrome-A Systematic Review, 2019, 25;11(10), 2291.
Kang Y., Cai Y.: Hormones: Gut microbiota and obesity: implications for faecal microbiota transplantation therapy, 2017, 16(3), 223-234.
Allegretti JR., Kassam Z., Mullish BH., Chiang A., Carrellas M., Hurtado J., Marchesi JR, McDonald JAK., Pechlivanis A., Barker GF., Miguéns Blanco J., Garcia-Perez I, Wong WF, Gerardin Y., Silverstein M., Kennedy K., Thompson C.: Clin Gastroenterol Hepatol: Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients, 2020, 18(4), 855-863.
Suganya K., Koo BS.: Int J Mol Sci: Gut-Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions, 2020, 13;21(20), 7551.
Borsom EM., Lee K., Cope EK.: Brain Sci: Do the Bugs in Your Gut Eat Your Memories? Relationship between Gut Microbiota and Alzheimer's Disease, 2020, 3;10(11), 814.
Nandwana V., Debbarma S.: Cureus: Fecal Microbiota Transplantation: A Microbiome Modulation Technique for Alzheimer's Disease, 2021, 20;13(7).
Wang H., Yang F., Zhang S., Xin R., Sun Y.: NPJ Parkinsons Dis: Genetic and environmental factors in Alzheimer's and Parkinson's diseases and promising therapeutic intervention via faecal microbiota transplantation, 2021, 11;7(1), 70.
Huang H., Xu H., Luo Q., He J., Li M., Chen H., Tang W., Nie Y., Zhou Y.: Medicine (Baltimore): Fecal microbiota transplantation to treat Parkinson's disease with constipation: A case report, 2019, 98(26).
Schepici G., Silvestro S., Bramanti P., Mazzon E.: Cell Transplant: The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials, 2019, 28(12), 1507-1527.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Emilia Nowak, Karolina Widłak, Piotr Pawłowski, Karolina Ziętara, Aleksadra Orzechowska , Aneta Kościołek, Iwona Adamska-Kuźmicka
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 503
Number of citations: 0
